San Francisco-based Moving Analytics, a digital health company, has raised an undisclosed amount of funding. The investor was OCA Ventures.
1 min read · 28 February 2017
Finland-based Enersize Oy, a developer of energy efficiency monitor and control software, has secured an undisclosed amount of funding. The investor was Scania Growth Capital, Swedish bus and truck maker Scania's new venture fund.
1 min read · 28 February 2017
Carmel, Indiana-based Lumavate LLC, a provider of mobile solutions for manufacturers and dealers, has raised $2 million in funding. Don Brown led the round with participation from other investors that included Elevate Ventures, Allos Ventures, 4G Ventures and Collina Ventures. In addition to the funding, the company has added John True to its board of managers.
1 min read · 28 February 2017
Dubset Media, a music technology and distribution company, has raised $4 million in Series A funding. Cue Ball Capital led the round.
1 min read · 27 February 2017
Anorak Ventures has raised $13 million for its debut fund, according to an SEC filing. Based in San Francisco, the venture firm focuses on early-stage disruptive technology.
1 min read · 27 February 2017
London-based Dealflo, a provider of financial agreement automation services, has raised 10 million pounds in funding. Holtzbrinck Ventures led the round with participation from Notion Capital and Frog Capital.
1 min read · 27 February 2017
Breakthrough Energy Ventures has named Eric Toone as executive managing director and science lead and David Danielson as managing director for science. Toone recently led the Innovation and Entrepreneurship Initiative at Duke University while Danielson was a Precourt Energy Scholar at Stanford University and prior to that, he worked seven years at the U.S. Department of Energy.
3 min read · 27 February 2017
Israel-based Pharma Two B Ltd, a biopharmaceutical company focused on developing treatments for Parkinson's disease, has secured $30 million in funding. Israel Biotech Fund led the round with participation from other investors that included JK&B and Generali Financial Holdings FCP-FIS SF2. In conjunction with the funding, Jeff Kindler, a member of Israel Biotech Fund's venture advisory team, has been added to Pharma Two B's board of directors.
1 min read · 27 February 2017
Waltham, Massachusetts-based Arrakis Therapeutics, a biopharmaceutical company, has closed $38 million in Series A financing. Canaan Partners led the round with participation from other investors that included Advent Life Sciences, Pfizer Inc, Celgene Corp and Osage University Partners. In addition to the funding, Arrakis has appointed Dr. Michael Gilman as chairman and CEO.
1 min read · 27 February 2017
Cordial, a maker of a messaging platform that helps brands adapt their messaging and digital experiences to the connected consumer, has secured $6 million in Series A funding. The investor was Upfront Ventures.
1 min read · 27 February 2017
